CaliberMRI Logo
  • Home
  • qMRI Solutions
    • View all qMRI Solutions
    • qCal-MR™ Software
    • Premium Diffusion Phantom
    • Premium System Phantom
    • System Phantom Lite
    • Premium Breast Phantom
    • Premium Prostate Phantom
  • About CMRI
    • Who is CMRI?
    • News
  • Partners
  • Resources
Contact
Request a quote
  • Home
  • qMRI Solutions
    • View all qMRI Solutions
    • qCal-MR™ Software
    • Diffusion Phantom
    • System Phantom
    • System Phantom Lite
    • Breast Phantom
    • Prostate Phantom
  • Our Company
  • News
  • Contact

[Paper] Artificial Intelligence for Breast MRI in 2008–2018: A Systematic Mapping Review

Oct 20, 2020 | qMRI Breast Resources

The purpose of this study was “to review literature from the past decade on applications of artificial intelligence (AI) to breast MRI.” Download Paper

[Paper] Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL

Oct 20, 2020 | qMRI Breast Resources

The purpose of this study was to, “This study was designed to determine (1) rates of clinically meaningful tumor reduction in breast tumor size following neoadjuvant chemotherapy (NAC), (2) which receptor subtypes and MRI phenotypes are associated with...

[Paper] Machine Learning-Based Prediction of Future Breast Cancer Using Algorithmically Measured Background Parenchymal Enhancement on High-Risk Screening MRI

Oct 20, 2020 | qMRI Breast Resources

The purpose of this study was “to determine if algorithmically extracted imaging features of BPE on screening breast MRI in high-risk women are associated with subsequent development of cancer.” Download Paper

[Paper] Radiomic versus Convolutional Neural Networks Analysis for Classification of Contrast-enhancing Lesions at Multiparametric Breast MRI

Oct 20, 2020 | qMRI Breast Resources

The purpose of this study was “to compare the diagnostic performance of radiomic analysis (RA) and a convolutional neural network (CNN) to radiologists for classification of contrast agent–enhancing lesions as benign or malignant at multiparametric breast...

Categories

  • Account Management
  • CaliberMRI Product Resources
  • Folder Search
  • Human Resource
  • Intro to qMRI
  • Press Release
  • qCal-MR Graphs
  • qCal-MR Studies
  • qMRI Brain Resources
  • qMRI Breast Resources
  • qMRI Prostate Resources
  • Study Search
  • Uncategorized

Recent Posts

  • How to Share Your qCal Study
  • The Comprehensive qMRI Abbreviations List
  • [Paper] Stability and reproducibility of co-electrospun brain-mimicking phantoms for quality assurance of diffusion MRI sequences
  • [Paper] Artificial Intelligence for Breast MRI in 2008–2018: A Systematic Mapping Review
  • [Paper] Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives
CaliberMRI Logo

CaliberMRI transforms The Known using quantitative MRI imaging phantoms and QA/QC cloud-based software into incredible human health insights for qMRI experts worldwide.

SEARCH

qMRI Solutions
  • qCal-MR™ QA/QC Software
  • Premium Diffusion Phantom
  • Premium System Phantom
  • System Phantom Lite
  • Premium Breast Phantom
  • Premium Prostate Phantom

About CaliberMRI

  • The CMRI Team
  • CMRI’s Mission
  • CMRI’s Partners
  • CMRI News

Contact CMRI

  • 4909 Nautilus Court North, Suite 121
    Boulder, Colorado 80301
    United States

  • info@qmri.com

  • +1-720-828-QMRI (7674)

qMRI Solutions

  • qCal-MR™ QA/QC Software
  • Diffusion Phantom
  • System Phantom
  • System Phantom Lite
  • Breast Phantom
  • Prostate Phantom

Our Company

  • Team
  • Mission
  • Our Partners

Contact MRI

  • 4601 Nautilus Court, Suite 100
    Boulder, Colorado 80301
    United States

  • info@qmri.com

  • +1-720-828-QMRI (7674)

Request a quote

Request a quote

© Copyright 2020 | All Rights Reserved 

We are using cookies to provide statistics that help us give you the best experience of our site, products and services.Ok